DeepAI AI Chat
Log In Sign Up

GeneDisco: A Benchmark for Experimental Design in Drug Discovery

by   Arash Mehrjou, et al.

In vitro cellular experimentation with genetic interventions, using for example CRISPR technologies, is an essential step in early-stage drug discovery and target validation that serves to assess initial hypotheses about causal associations between biological mechanisms and disease pathologies. With billions of potential hypotheses to test, the experimental design space for in vitro genetic experiments is extremely vast, and the available experimental capacity - even at the largest research institutions in the world - pales in relation to the size of this biological hypothesis space. Machine learning methods, such as active and reinforcement learning, could aid in optimally exploring the vast biological space by integrating prior knowledge from various information sources as well as extrapolating to yet unexplored areas of the experimental design space based on available data. However, there exist no standardised benchmarks and data sets for this challenging task and little research has been conducted in this area to date. Here, we introduce GeneDisco, a benchmark suite for evaluating active learning algorithms for experimental design in drug discovery. GeneDisco contains a curated set of multiple publicly available experimental data sets as well as open-source implementations of state-of-the-art active learning policies for experimental design and exploration.


page 8

page 20

page 21

page 26

page 27


CausalBench: A Large-scale Benchmark for Network Inference from Single-cell Perturbation Data

Mapping biological mechanisms in cellular systems is a fundamental step ...

Deciding when to stop: Efficient stopping of active learning guided drug-target prediction

Active learning has shown to reduce the number of experiments needed to ...

Curiosity in exploring chemical space: Intrinsic rewards for deep molecular reinforcement learning

Computer-aided design of molecules has the potential to disrupt the fiel...

Multi-Fidelity Active Learning with GFlowNets

In the last decades, the capacity to generate large amounts of data in s...

Bayes Optimal Informer Sets for Early-Stage Drug Discovery

An important experimental design problem in early-stage drug discovery i...

AGATHA: Automatic Graph-mining And Transformer based Hypothesis generation Approach

Medical research is risky and expensive. Drug discovery, as an example, ...